Form 4 · Filed May 5, 2026, 11:08 PM UTC
EW/Edwards Lifesciences Corp
Ullem Scott B. — CVP, Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 5, 2026 | M | other | 13,000 | $59 | $770,337 | 52,079 |
| May 5, 2026 | F | other | 11,131 | $83 | $922,871 | 40,948 |
| May 5, 2026 | M | other | 13,000 | $0 | $0 | 0 |
| May 3, 2026 | F | other | 620 | $84 | $52,068 | 39,079 |
Source: SEC EDGAR raw filing ↗ · Accession 0001225208-26-004969